Cybersecurity has become an important part of medical device development. As medical devices become more connected, software-driven, and capable of sharing data, manufacturers must demonstrate that cybersecurity risks have been considered throughout the product lifecycle.
FDA Cybersecurity Documentation provides evidence that cybersecurity activities have been planned, implemented, and maintained to help protect medical devices from potential security threats.
Well-prepared cybersecurity documentation helps manufacturers:
A structured cybersecurity program not only supports regulatory expectations but also helps organizations develop safer and more reliable medical devices.
Structured support for medical device and digital health organizations preparing cybersecurity documentation for FDA submissions, product development, and post-market compliance.
Practical documentation and regulatory-readiness support to help organizations prepare cybersecurity evidence for FDA submissions and manage cybersecurity across the product lifecycle.
Practical, end-to-end support for medical device cybersecurity documentation, regulatory submission readiness, and secure product lifecycle management.
FAQ
FDA Cybersecurity Documentation is a collection of records, reports, and supporting evidence that demonstrate how cybersecurity has been addressed during the development and maintenance of a medical device.
Medical devices that contain software, connect to networks, exchange data, or have cybersecurity-related risks generally require cybersecurity considerations and supporting documentation.
A Software Bill of Materials (SBOM) is a list of software components used within a device or software application that helps improve transparency and vulnerability management.
Yes. We assist organizations in identifying cybersecurity risks and documenting appropriate controls and mitigation measures.
Yes. We provide documentation support, gap assessments, and guidance to help organizations prepare cybersecurity documentation for regulatory submissions.
Fill in the form and our team will get back to you shortly.
Reach our regulatory experts directly.